drugset / Trial / NCT00118417

Therapies for Treatment-Resistant Panic Disorder Symptoms

NCT00118417

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.

Timeline

Start
1999-03
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule
Subject Sertraline Small molecule 100 mg
Subject Sertraline Small molecule 200 mg

Indications